Skip to main content

Table 1 Demographic and Clinical Characteristics of subjects

From: The prevalence of lower urinary tract symptoms based on individual and clinical parameters in patients with multiple sclerosis

Parameter  
Age (year) [Mean (SD)] 35.45 (8.08)
Disease Duration [Mean (SD)] 7.63 (5.56)
Age of onset of disease [Mean (SD)] 26.85(7.81)
Sex [n (%)]
 Female 474 (78.7)
 Male 128 (21.3)
Marital status [n (%)]
 Single 149 (24.8)
 Married 415 (68.9)
 Divorced and widowed 38 (6.3)
Education level [n (%)]
 Secondary school or below 145 (24)
 high school 214 (35.5)
 University 244 (40.5)
Job status [n (%)]
 Employed 128 (21.2)
 Unemployed 52 (8.6)
 housewife 378 (62.7)
 Retired and disabled 45 (7.5)
Current comorbid conditions [n (%)]
 Diabetes 7 (1.2)
 Arthritis 8 (1.3)
 Hypertension 17 (2.8)
 Heart disease 5 (0.8)
 Thyroid disorders 40 (6.6)
 Migraine 37 (6.1)
 Asthma 8 (1.3)
 Inflammatory bowel disease 9 (1.5)
 kidney disease 14 (2.3)
 Liver disease 4 (0.7)
 infectious disorders 2 (0.3)
 Skin disorders 2 (0.3)
 Epilepsy 11 (1.8)
 Other disorders 64 (10.6)
 None 375 (62.1)
EDSS Score [Mean (SD)] 2.45 (2.11)
EDSS Class [n (%)]
 Mild (1–3) 432 (71.6)
 Moderate (3.5–6.5) 151 (25)
 Severe (≥ 7) 20 (3.4)
Course disease [n (%)]
 Relapsing remitting 459 (76.1)
 Primary progressive 19 (3.2)
 Secondary progressive 97 (16.1)
 CIS 28 (4.6)
MS medication [n (%)]
 Interferon beta 203 (33.7)
 Glatiramer acetate 47 (7.8)
 Fingolimod 114 (18.9)
 Natalizumab injection 41 (6.8)
 Azathioprine 20 (3.3)
 Ritoximab injection 97 (16.1)
 Mitoxantrone 1 (0.2)
 Dimethilfumarat 13 (2.2)
 Trifulonumaide 4 (0.7)
 Mix (Azathioprine&Interferonbeta) 24 (4)
 Cyclophosmaide 8 (1.3)
 Metotruxat 3 (0.5)
 None 28 (4.6)
Symptomatic treatment [n (%)]
 Anti-depressant 119(19.8)
 Anticonvulsants 111(18.4)
 Anti-anxiety 40(6.6)
 Antipsychotic 17(2.8)
 Anticholinergic 103(17.1)
 anti-spasticity 86(14.3)
 Anti-fatigue 56(9.3)
 Beta blocker 37(6.1)
 Levothyroxine 26(4.3)
 anti-Anemia 35(5.8)
 Amantadine 15(2.5)
 supplements 377(62.6)
 Anti-lipid 8(1.3)
 NSAID 10(1.7)
 Alpha Adrenergic Inhibitor 16(2.7)
 Anti-acid 39(6.5)
 Modafinil 8(1.3)
  1. SD: Standard deviation; EDSS: Expanded Disability Status Scale